• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. XIENCE SKYPOINT¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 1804300-28
Patient Problems Chest Pain (1776); Thrombosis/Thrombus (4440)
Event Date 12/22/2023
Event Type  malfunction  
Event Description
Per cardiac catheterization note - i attempted to cross the blockage with xience skypoint¿ stent however it would not cross.While it was being retrieved, stent came off the balloon in the proximal circumflex.There was still thrombolysis in myocardial infarction (timi) 3 flow however at this point.I focused to cross the stent struts against the vessel wall.Multiple wires, balloon and support catheters were used including pilot, fielder, run-through, whisper along with turnpike versus small support balloons but i could not cross beyond this segment.Patient was having active pain for which i decided to stabilize left main into left anterior descending artery (lad).3.5 x 30 onyx stent was then deployed from mid left main into proximal lad.Same stent balloon was used for post dilation of this stented segment.Further postdilation was done using 4.0 noncompliant balloon in left main and proximal lad.I attempted to rewire the circumflex with the stent struts, and i was able to get through the proximal stent where i had a 2.0 balloon to open up stent struts.I could still not go beyond mid circumflex where stent had dislodged.I decided to accept this result as further attempts were likely going to be unsuccessful.Impella was weaned off.Brilinta had been loaded and will be continued.Impella was removed.Preclose's were deployed and patent hemostasis was achieved.The patient tolerated the procedure well and left the cardiac catheterization laboratory pain-free and stable condition where he was taken back to an electrocardiographic a monitored site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
ABBOTT VASCULAR INC.
one lillehei plaza
saint paul MN 55117
MDR Report Key18685245
MDR Text Key335125358
Report Number18685245
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 12/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/12/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1804300-28
Device Catalogue Number1804300-28
Device Lot Number2101341
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/26/2023
Event Location Hospital
Date Report to Manufacturer02/12/2024
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age76 YR
-
-